Genkyotex announces the closing of the acquisition by Calliditas Therapeutics of a controlling interest in Genkyotex
Genkyotex (Euronext Paris & Brussels: FR0013399474 –GKTX), a biopharmaceutical company and the leader in NOX therapies, announced the closing of the acquisition by Calliditas Therapeutics AB (“Calliditas”; Nasdaq OMX ...